| Stage | ALGM | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $277M | 100.00% | $96.2B | 100.00% | NVDA ×347.51 |
| Gross profit | $136M | 49.18% | $72.1B | 74.98% | NVDA +25.8pp |
| Operating income | $35M | 12.80% | $63.7B | 66.24% | NVDA +53.4pp |
| Pre-tax income | $28M | 10.05% | $71.5B | 74.32% | NVDA +64.3pp |
| Net income | $23M | 8.42% | $59.7B | 62.03% | NVDA +53.6pp |
| Stage | ALGM | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $277M100.00% | $96.2B100.00% | NVDA ×347.51 |
| Gross profit | 49.18%$136M | 74.98%$72.1B | NVDA +25.8pp |
| Operating income | 12.80%$35M | 66.24%$63.7B | NVDA +53.4pp |
| Pre-tax income | 10.05%$28M | 74.32%$71.5B | NVDA +64.3pp |
| Net income |
| 8.42%$23M |
| 62.03%$59.7B |
| NVDA +53.6pp |
No shared counterparties.